Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
BCAB BioAtla
- 0.692
- -0.498-41.82%
Close Dec 20 16:00 ET
- 0.739
- +0.047+6.75%
Post 19:59 ET
33.47MMarket Cap-0.41P/E (TTM)
1.080High0.670Low6.25MVolume1.080Open1.190Pre Close4.93MTurnover17.94%Turnover RatioLossP/E (Static)48.35MShares4.02052wk High1.46P/B24.10MFloat Cap0.67052wk Low--Dividend TTM34.82MShs Float76.630Historical High--Div YieldTTM34.45%Amplitude0.670Historical Low0.788Avg Price1Lot Size
About BioAtla Company
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees65
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708
Websitehttp://www.BioAtla.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay M. Short,PhD
- Chairman of the Board and Chief Executive Officer
- 3.30M
- Richard A. Waldron
- Senior Vice President and Chief Financial Officer
- 1.24M
- Dr. Eric Sievers, M.D.
- Chief Medical Officer
- 1.32M
- Christian Vasquez
- Chief Accounting Officer, Controller and Corporate Secretary
- --
- Scott A. Smith
- Director
- 1.27M
- Edward Williams
- Independent Director
- 168.94K
- Sylvia McBrinn
- Independent Director
- 164.57K
- Dr. Mary Ann Gray,PhD
- Independent Director
- 180.44K
- Dr. Susan Moran, M.D.
- Independent Director
- 158.19K
- Dr. Lawrence J. Steinman, M.D.
- Independent Director
- 161.19K